Bristol Myers, 2seventy: Earlier Abecma Use Advances With Three Regulators
Bristol Myers, 2seventy: Earlier Abecma Use Advances With Three Regulators...…
54,950€
1,22%
Echtzeit-Aktienkurs Bristol-Myers Squibb Co.
Bid:
Ask:
Nachrichten zur Bristol-Myers Squibb Co. Aktie
Bristol Myers Squibb (BMY) Gains But Lags Market: What You Should Know
In the latest trading session, Bristol Myers Squibb (BMY) closed at $70.69, marking a +0.68% move from the previous day....…
Cellares Hires Former Novartis Executive and Bristol-Myers Squibb Alum to Lead Commercialization
SOUTH SAN FRANCISCO, Calif., April 12, 2023 /PRNewswire/ -- Cellares, a biotech company dedicated to making life-saving cell therapies accessible…
Will Bristol Myers (BMY) Beat Estimates Again in Its Next Earnings Report?
Bristol Myers (BMY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients…
XFRA : DIVIDEND/INTEREST INFORMATION - 06.04.2023 - US1101221083
Das Instrument BRM US1101221083 BRISTOL-MYERS SQUIBBDL-10 EQUITY wird cum Dividende/Zinsen gehandelt am 05.04.2023 und ex Dividende/Zinsen am 06.04.2023
The instrument BRM…
Bristol Myers Squibb (BMY) Outpaces Stock Market Gains: What You Should Know
In the latest trading session, Bristol Myers Squibb (BMY) closed at $69.69, marking a +0.55% move from the previous day....…
Reunion Neuroscience Appoints Dr. Fred Grossman to Board of Directors
- Seasoned Psychiatrist and Global Pharmaceutical R&D Executive with Over Two Decades of Experience in Clinical Development, Including at Eli…
Bristol-Myers Squibb Unusual Options Activity For March 31
read more...…
Bristol Myers Gets CHMP Backing for Second-Line Breyanzi >BMY
Bristol Myers Gets CHMP Backing for Second-Line Breyanzi >BMY...…
Evotec: Die Kooperation mit Bristol-Myers Squibb verlängert und erweitert - Aktienanalyse
Kulmbach (www.aktiencheck.de) - Evotec-Aktienanalyse von "Der Aktionär":
Marion Schlegel vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie der…
Evotec: Deal beflügelt, „Erntezeit beginnt“
Evotec hat am Dienstag die Zahlen für das vergangenen Geschäftsjahr sowie einen Ausblick für 2023 veröffentlicht. Die Aktie reagierte zunächst…
Bristol Myers Squibb (BMY) Gains As Market Dips: What You Should Know
In the latest trading session, Bristol Myers Squibb (BMY) closed at $68.20, marking a +0.19% move from the previous day....…
Bristol Myers (BMY) Gets Approval of Psoriasis Drug in EU
Bristol Myers (BMY) Sotyktu gets approval from the European Commission to treat adults with moderate-to-severe plaque psoriasis who are candidates…
Is Eli Lilly or Bristol Myers Squibb the Better Value Stock to Buy Right Now?
One of these big pharma stocks is considerably more attractive as a pure-play value investment....…
Evotec Stock Up As It Extends Neurodegeneration Partnership With Bristol Myers Squibb
NEW YORK CITY (dpa-AFX) - Shares of Evotec SE (EVO) were gaining around 4 percent in the German trading after…
Evotec gets $50M upfront from Bristol Myers in pact to develop neuro disease drugs
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Evotec Extends Partnership With Bristol Myers Squibb for Potential $4 Bln
Evotec Extends Partnership With Bristol Myers Squibb for Potential $4 Bln...…
Evotec verlängert Kooperation mit BMS zu neurodegenerativen Krankheiten
HAMBURG (dpa-AFX) - Die Zusammenarbeit mit dem US-Pharmakonzern Bristol Myers Squibb (BMS) zahlt sich für den Wirkstoffforscher Evotec (EVOTEC SE)…
Evotec SE: Evotec and Bristol Myers Squibb Extend and Expand Strategic Neurodegeneration Partnership
8-YEAR EXTENSION AND EXPANSION OF ONGOING COLLABORATION TO DEVELOP A BROADENED PROGRAMME PIPELINE IN NEURODEGENERATIVE DISEASESPARTNERSHIP LEVERAGES EVOTECS PRECISION MEDICINE…
EVOTEC-Aktie gefragt: EVOTEC überzeugt beim Umsatz und patzt beim operativen Gewinn - Partnerschaft mit Bristol Myers Squibb erneuert
EVOTEC hat im abgelaufenen Jahr den Umsatz gesteigert und die eigene Prognose übertroffen, allerdings sank der operative Gewinn und landete…
Evotec und Bristol Myers Squibb erweitern Neurologie-Partnerschaft
FRANKFURT (Dow Jones)--Evotec und Bristol Myers Squibb haben ihre strategische Partnerschaft im Bereich neurodegenerative Erkrankungen erweitert und um acht Jahre…
Corporate News: Evotec SE
Evotec und Bristol Myers Squibb verlängern und erweitern strategische Neurologie-Partnerschaft...…
Bristol Myers Squibb (BMY) Stock Moves -0.4%: What You Should Know
Bristol Myers Squibb (BMY) closed at $67.24 in the latest trading session, marking a -0.4% move from the prior day....…
Is Bristol Myers Squibb Stock A Better Pick Over Its Industry Peer?
Investors have assigned a higher multiple to LLY stock due to its robust pipeline and better profitability, as discussed below…
Bristol Myers Squibb (BMY) Stock Sinks As Market Gains: What You Should Know
In the latest trading session, Bristol Myers Squibb (BMY) closed at $67.10, marking a -0.56% move from the previous day....…
Evotec Shares Rise After Drug Progress Earns Payment From Bristol Myers Squibb
Evotec Shares Rise After Drug Progress Earns Payment From Bristol Myers Squibb...…
Evotec Announces Progress In Protein Degradation Partnership With Bristol Myers
NEW YORK CITY (dpa-AFX) - Evotec SE (EVO) announced progress in strategic protein degradation partnership with Bristol Myers Squibb. Performance-based…
Evotec SE: Evotec Announces Progress in Strategic Protein Degradation Partnership with Bristol Myers Squibb
KEY SCIENTIFIC ACHIEVEMENTS DRIVE THE EXPANSION OF THE PIPELINE OF MOLECULAR GLUE DEGRADERSPERFORMANCE-BASED AND PROGRAMME-BASED PAYMENTS OF IN TOTAL US$…
Evotec erhält 75 Mio Dollar aus Bristol-Myers-Partnerschaft
FRANKFURT (Dow Jones)--Evotec macht im Rahmen der Partnerschaft mit Bristol Myers Squibb bei der Pipelineentwicklung von Molecular Glues Fortschritte und…
Fortschritte in Forschungskooperation mit BMS: Evotec erhält Millionenzahlung
HAMBURG (dpa-AFX) - Der Wirkstoffforscher Evotec (EVOTEC SE) erhält nach Fortschritten in der Kooperation mit dem Pharmakonzern Bristol Myers Squibb…
Mediar Therapeutics announces $105m financing to advance fibrosis therapies
The Series A round was co-led by Novartis Venture Fund and Sofinnova Partners and has seen participation from Pfizer Ventures,…
Corporate News: Evotec SE
Evotec verkündet Fortschritte in strategischer Partnerschaft mit Bristol Myers Squibb im Bereich Protein Degradation...…
Bristol Myers, Pfizer, AbbVie drugs likely to face U.S. price negotiation
.../WASHINGTON (Reuters) - The blood thinner Eliquis from Bristol Myers... and academic analyses shared with Reuters.
…
Should Investors Buy Bristol Myers or CVS Stock Near 52-week Lows?
Investors are often on the lookout for strong companies that may be undervalued and present lucrative long-term opportunities....…
Bristol Myers Squibb (BMY) Stock Moves -1.19%: What You Should Know
In the latest trading session, Bristol Myers Squibb (BMY) closed at $65.72, marking a -1.19% move from the previous day....…
Bristol Myers (BMY) Gets EU Nod for Anemia Drug Reblozyl
Bristol Myers Squibb (BMY) gets full marketing authorization from the European Commission, for Reblozyl for anemia associated with non-transfusion-dependent beta…
Bristol-Myers Squibb Company declares $0.57 dividend
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Viz.ai schließt Vereinbarung mit Bristol Myers Squibb, um frühere Erkennung und Behandlung von vermuteter hypertropher Kardiomyopathie (HCM) zu ermöglichen
SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, ein führendes Unternehmen im Bereich der KI-gestützten Krankheitserkennung und Pflegekoordination, gab heute eine mehrjährige Vereinbarung mit Bristol…
Bristol Myers, Janssen launch late-stage Librexia program evaluating milvexian
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Bristol Myers wins $6.4B lawsuit over cancer drug delay
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Bristol Myers wins dismissal of lawsuit over Celgene drugs
...NEW YORK (Reuters) - A U.S. judge on Wednesday dismissed......…
Bristol Myers Opdivo for skin cancer gets review in US, EU
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 8-K BRISTOL MYERS SQUIBB CO For: Feb 23
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Friendly Forces Partners with Bristol Myers Squibb to Promote Pro-Reservist Policies and Hiring
WASHINGTON, Feb. 23, 2023 /PRNewswire/ -- Friendly Forces, a new company that identifies employers of choice for military reservists, makes…
Bristol Myers Squibb Company: Basketball Legend Kareem Abdul-Jabbar Joins No Time to Wait Campaign to Raise Awareness of Atrial Fibrillation and its Symptoms
PRINCETON, NJ and NEW YORK, NY / ACCESSWIRE / February 21, 2023 / Bristol Myers Squibb CompanyOriginally published on Bristol…
Lung Cancer Drugs Global Market Report 2023
NEW YORK, Feb. 21, 2023 /PRNewswire/ -- Major players in the lung cancer market are Bristol-Myers Squibb Company, Merck &…
Bladder Cancer Drugs Global Market Report 2023
NEW YORK, Feb. 17, 2023 /PRNewswire/ --Major players in the bladder cancer drugs market are Pfizer, Celgene Corporation, Eli Lilly,…
Why Bristol Myers Squibb (BMY) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores....…
Cervical Cancer Drugs Global Market Report 2023
NEW YORK, Feb. 16, 2023 /PRNewswire/ -- Major players in the cervical cancer drugs market are F. Hoffmann-La Roche Ltd,…
Skye Bioscience Appoints Deborah Charych, PhD to Board of Directors
San Diego, California--(Newsfile Corp. - February 16, 2023) - Skye Bioscience, Inc. (OTCQB: SKYE) ("Skye" or the "Company"), a pharmaceutical…